Kiri
| Dokumendiregister | Sotsiaalministeerium |
| Viit | 1.5-8/1586-1 |
| Registreeritud | 11.06.2025 |
| Sünkroonitud | 12.06.2025 |
| Liik | Sissetulev kiri |
| Funktsioon | 1.5 Asjaajamine. Info- ja kommunikatsioonitehnoloogia arendus ja haldus |
| Sari | 1.5-8 Tervitus- ja tutvustuskirjad, kutsed ja kirjavahetus seminaridel, konverentsidel jt üritustel osalemiseks |
| Toimik | 1.5-8/2025 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | Healthcare Denmark |
| Saabumis/saatmisviis | Healthcare Denmark |
| Vastutaja | Agne Nettan-Sepp (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond) |
| Originaal | Ava uues aknas |
Failid
1
Copenhagen Life Science Summit October 8-9
With a predominant focus on human health, the forthcoming European life science strategy will be an example of a forward-looking policy that intend to harness the poten<al of innova<on and new technologies while upholding the core principles of universal access to high-quality care – a hallmark of healthcare in Europe.
With the Compe<<veness Compass, the EU Commission has set a new poli<cal direc<on in which research and innova<on is at the heart of boos<ng European compe<<veness to ensure sustainable prosperity, aiming to develop and produce tomorrow's technologies – made in Europe innova<on. The Draghi Report highlights the life science industry, encompassing both pharmaceu<cals and medical devices, as an example of what the EU can achieve in technology and innova<ve product development.
On October 8-9, Rigshospitalet and Healthcare Denmark will host Copenhagen Life Science Summit as part of Denmark's EU Presidency (July 1 - December 31, 2025), which will be included in the official conference programme during the Presidency, focusing on the life science sector in a European context.
Copenhagen Life Science Summit will explore the state of the current EU health ecosystem in a global context highligh<ng the role for a strong ecosystem approach to European coopera<on between industry, academia, public health authori<es and pa<ents. The summit will contribute to the promo<on of Europe as a leading life science region, where new innova<ve health solu<ons are to the benefit of pa<ents and the European health systems.
The forthcoming EU Strategy for Life Sciences adopts an approach where “life sciences” as a term is broadly understood as the study of living systems, from microorganisms, plants, animals and human beings to ecosystems. It encompasses sectors from pharmaceu<cals to agriculture, energy, food and feed. The strategy will iden<fy key challenges and opportuni<es to speed up the safe development, deployment and uptake of life sciences-based innova<on, including to support the digital and green transi<ons of our society and economy. In this context Copenhagen Life Science Summit focuses specifically on life sciences in rela<on to human health. It includes research, innova<on, commercializa<on, scale up and implementa<on in pharmaceu<cals, biotechnology and medical technology as well as AI and other data driven and digitally enabled health care solu<on.
Copenhagen Life Science Summit aims to facilitate broad stakeholder discussions on a number of thema<c topics with the objec<ve to shape policy discussions and the EU Strategy for Life Sciences:
• On October 8, Rigshospitalet will host a high-level conference day: “Invest, Innovate, Collaborate, Elevate: Strategic Perspec<ves for an Innova<ve and Compe<<ve European Life Sciences Ecosystem" that will discuss and shape policy recommenda<ons in the context of the EU Strategy for Life Sciences. The conference will focus on transla<onal research and clinical trials, life science innova<on ecosystems, uptake of innova<ve health solu<ons and interdisciplinary infrastructures for transforma<ve life science R&I.
On October 8, Healthcare Denmark will host a standing dinner recep<on in Copenhagen City Hall.
• On October 9, Healthcare Denmark will host a high-level conference day: "Life Science: A Catalyst for European Compe<<veness" that will discuss how the European life science sector will be a catalyst for compe<<veness with a close link to the EU Compass. The conference will focus on how Europe, through public-private partnerships, can enhance compe<<veness and aaain strategic autonomy.
2
Preliminary Programme Wednesday October 8 Invest, Innovate, Collaborate, Elevate: Strategic Perspec7ves for an Innova7ve and Compe77ve European Life Sciences Ecosystem Venue: Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen
Time Content Speakers
8:30 Arrival, registra<on and networking
09:00 Welcome and fireside discussion
• Welcome by Rasmus Møgelvang, CEO, Rigshospitalet and Lars Gaardhøj, Chairman, Capital Region of Denmark.
• Fireside discussion by Margrethe Vestager and Enrico Le@a
(tbc) Moderator: Di@e Brasso Sørensen, Deputy Director, Think Tank EUROPA
09:30 Panel discussion
State of the current EU health ecosystem in a global context Moderated by: Di@e Brasso Sørensen, Deputy Director, Think Tank EUROPA • Elizabeth Macintyre, President, Biomedical Alliance in
Europe • Nathalie Moll, CEO, EFPIA (tbc) • Oliver Bisazza, CEO, MedTech Europe (tbc) • Ernst Kuipers, Vice President (Research), Nanyang
Technological University, Singapore; and Prev. Minister of Health, Welfare and Sport of the Netherlands
• Marco Greco, President of European Pa<ents Forum (tbc)
10:15 IntroducMon to break-out discussion by Di@e Brasso Sørensen, Deputy Director, Think Tank EUROPA
10:30 Coffee break
11:00 Walk to Roundtable discussions
3
11:15 Roundtable discussions
RTD 1: Strengthening applied transnaMonal and clinical research By Chair, CrisMna Messa, former Minister of University and Research, Italy; and Co-chair, Malene Fischer, Research Director, Rigshospitalet. RTD 2: BoosMng the innovaMon of the European life science industry By Chair, Prof. Chantal Mathieu, KU Leuven (tbc); and Co-chair, David Dreyer Lassen, Rector, University of Copenhagen. RTD3: SupporMng the uptake and implementaMon of medical technologies and health care soluMons By Chair, Heyo Kroemer, CEO, Charité (tbc); and Co-chair, Rasmus Møgelvang, CEO, Rigshospitalet. RTD 4: Securing EU as a world leader in personalised medicine and prevenMon By Chair, Jens Habermann, CEO, BBMRI-ERIC (tbc); and Co-chair: BeZna Lundgren, CEO, Danish Na<onal Genome Center (tbc). RTD 5: Addressing European regulatory challenges By Chair, Enrico Le@a, IE University’s School of Poli<cs, Economics and Global Affairs (tbc); and Co-chair Ida Sofie Jensen, CEO, Lif.
12:45 Walk to lunch area
13:00 Lunch & networking
14:00 Panel debate How to create a world class European Ecosystem in life sciences Moderator: Di@e Brasso Sørensen, Deputy Director, Think Tank EUROPA • David Dreyer Lassen, Rector, Copenhagen University • Thomas Hoffmann, Director, Technical University Munich,
Innova<on District Munich (tbc) • Rasmus Møgelvang, CEO, Rigshospitalet, Innova<on District
Copenhagen • TBA
14:30 Pre-
recommenda<ons from Roundtable discussions
• Applied translaMon and clinical research, by chair • Cross-sectoral partnerships and innovaMon districts, by chair • AdopMng efficient innovaMve soluMons while eliminaMng low
benefit health care, by chair
4
• A world leader in personalised medicine and prevenMon. How to make the most of data sharing, digitalisaMon, and the use of AI, by chair
• Addressing European regulatory challenges, by chair
15:20 Short break
15:40 Keynote • Mario Draghi, former President of European Central Bank & Author of the Future European Compe<<veness Report (tbc)
16:00 High level panel
debate Moderator: Di@e Brasso Sørensen, Deputy Director, Think Tank EUROPA • Ekatarina Zaharieva, Commissioner for Startups, Research,
and Innova<on, European Commission (tbc) • ChrisMna Egelund, Minister for Higher Educa<on & Science,
Denmark • European minister of health • Rasmus Møgelvang, CEO, Rigshospitalet
16:30 End of conference
5
Wednesday October 8 Life Science: A Catalyst for European Compe77veness Venue: Copenhagen City Hall, Raadhuspladsen 1, Copenhagen
Time Content Speakers
RecepMon at Copenhagen City Hall
17.30 Arrival, registra<on and networking
18.00 Welcome
Lars Weiss, Lord Mayor, Copenhagen
18.10 Opening remarks
Sophie Løhde, Minister for the Interior and Health, Denmark
18.30 Networking dinner
20.00 End of recep<on
Thursday October 9 Life Science: A Catalyst for European Compe77veness Venue: Mærsk Tower, Copenhagen University, Blegdamsvej 3B, Copenhagen N
Time Content Speakers
08.00 Arrival, registra<on and networking
09.00 Welcome and opening remarks
David Dreyer Lassen, Rector, University of Copenhagen & Lykke Friis, Director, Think Tank EUROPA
09.15 Opening Keynote Unlocking Europe’s PotenMal: A Life Sciences Strategy for Prosperity and Health • Stéphane Séjourné, Execu<ve Vice-President for Prosperity and
Industrial Strategy, European Commission (TBC) The opening keynote will present the Commission’s vision for strengthening Europe’s life sciences sector, detailing key policy
6
ini<a<ves under the Strategy for Life Sciences and the Compe<<veness Compass.
09.35 Keynote Losing Ground? Challenges for Europe’s Life Sciences Sector in the Global Race for InnovaMon • Elizabeth Kuiper, Associate Director and Head of the Social
Europe & Well-Being Programme, European Policy Centre The keynote will assess the core drivers of Europe’s compe<<veness in life sciences and iden<fy future policy challenges for the EU.
09.55 Panel Debate Back in the Lead: How to Design a European Industrial Policy for Public Health and InnovaMon Moderated by: Lykke Friis, Director, Think Tank EUROPA • Ekaterina Zaharieva, Commissioner for Startups, Research, and
Innova<on, European Commission (TBC) • Stefan Oelrich, President, European Federa<on of
Pharmaceu<cal Industries and Associa<on (TBC) • Mónica García Gómez, Minister of Health, Spain (TBC) • CEO, Novo Nordisk (TBC) • Dolors Montserrat, MEP; Member of Commiaee on the
Environment, Climate and Food Safety (ENVI), European Parliament (TBC)
The panel will debate the priori<es for EU industrial policy by exploring the risks and poten<al of tools such as public investment, policy reform, and joint procurement to drive innova<on in life sciences while advancing European public health objec<ves.
10.40 Coffee Break
11.10 Fireside chat Aligning Public Goals with Corporate Growth: Lessons from the Nordic Experience Moderated by: Lykke Friis, Director, Think Tank EUROPA • Lars Rasmussen, Chair of the Board for Coloplast and WS
Audiology; Chair of the Danish Life Science Council This session will present the lessons learned from the Nordic approach to public-private partnerships and explore how these strategies could be scaled at the European level.
7
11.25 Panel Debate Public-Private Partnerships: A Catalyst for European CompeMMveness and Health? Moderated by: Lykke Friis, Director, Think Tank EUROPA • Jennifer Carroll MacNeill, Minister for Health, Ireland (TBC) • KersMn Jorna, Director-General for DG Internal Market, Industry,
Entrepreneurship and SMEs (DG GROW), European Commission (TBC)
• Charl Van Zyl, CEO, H. Lundbeck • SMne Bosse, MEP, Vice-Chair on the Commiaee on Public Health
(SANT), European Parliament (TBC) The panel will examine the role of public-private partnerships in fostering life sciences innova<on and strengthening healthcare. Speakers will discuss how Europe can build more effec<ve na<onal and cross-border collabora<ons between the public and private sectors.
12.10 Networking Lunch
13.10 Keynote Why life science must be at the heart of Europe’s industrial strategy to drive innovaMon, economic resilience, and public health • Morten Bødskov, Minister for Industry, Business and Financial
Affairs, Denmark
13.30 Panel Debate Unlocking the Societal Value of InnovaMon: Shaping the Future of Resilient, Sustainable and InnovaMve Healthcare in Europe Moderated by: Di@e Brasso Sørensen, Deputy Director, ThinkTank EUROPA • Sandra Gallina, Director-General for DG for Health and Food
Safety (DG SANTE), European Commission • Søren Nedergaard, CPO - Porpolio, People & Partnerships, Novo
Nordisk Founda<on • Teresa Graham, CEO, Roche Pharmaceu<cal • Marco Greco, President, European Pa<ents Forum (TBC)
The conversa<on will assess how strategic investments in life sciences can strengthen healthcare systems across Europe through economic growth and improved pa<ent outcomes.
8
14.15 Keynote Aligning Public Goals with Corporate Growth: Lessons from Europe • Marc Ferracci, Minister for Industry and Energy, France (TBC)
14.30 Panel debate How to Boost Private Investment in Start-ups and Scale-ups: The
Role of RegulaMon and Capital Market Reform Moderated by: Di@e Brasso Sørensen, Deputy Director, ThinkTank EUROPA • Gelsomina VigloZ, Vice President, European Investment Bank
(TBC) • Jens Nielsen, CEO, BioInnova<on Ins<tute Founda<on,
Copenhagen • Kim Jørgensen (To be announced) • Rafaele Tordjman, Founder and CEO, Jeito Capital (TBC) • Pascal Canfin, MEP, Member of the Commiaee on the
Environment, Climate and Food (ENVI); and the Commiaee of Public Health (SANT), European Parliament (TBC)
This session will debate how the EU can bridge the private investment gap in life science research and innova<on – in par<cular what regulatory reforms are needed to unlock private funding and how the EU can steer capital markets towards socially beneficial investments.
15.15 Coffee Break
15.45 Panel Debate Spreading the Gains of CompeMMveness: Enhancing Access to InnovaMve Healthcare Across the EU Moderated by: Di@e Brasso Sørensen, Deputy Director, ThinkTank EUROPA • Anca Toma, Execu<ve Director, European Pa<ents Forum (TBC) • VlasMmil Válek, Deputy Prime Minister and Minister of Health,
Czech Republic (TBC) • Benjamin Roche@e, Vice President, Global Regulatory Affairs,
Coloplast • Audrey Duval, Execu<ve Vice President of Corporate Affairs,
Sanofi (TBC) • Radan Kanev, MEP, Member of the Commiaee on the
Environment, Climate and Food (ENVI), European Parliament (TBC)
9
The panel will discuss how the EU’s industrial strategy should be accompanied by measures to improve equitable access to innova<ve treatments and ensure that investments in new life sciences hubs deliver benefits across all member states, for example through regulatory reform, financing condi<onali<es, stronger coordina<on, or joint procurement.
16.30 Closing Remarks
Moving Forward: Next Steps for Europe • Lars Løkke Rasmussen, Minister for Foreign Affairs, Denmark
(TBC) The closing remarks will reflect on key takeaways from the conference and highlight ac<onable next steps for policymakers to reinforce Europe’s leadership in life sciences.
16.45 End of conference
16.45 Closing Recep<on
18.00 End of Closing Recep<on
Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. |
Dear Minister of Social Affairs of Estonia, Karmen Joller,
On behalf of Denmark’s Presidency of the Council of the European Union, it is with great pleasure that Rigshospitalet, Healthcare Denmark and our partners extend a save-the-date invitation for the upcoming EU-conference Copenhagen Life Science Summit. The conference will be held on October 8-9, 2025, in Copenhagen, Denmark.
Attached to this email, you will find your personal save-the-date invitation and the preliminary programme. A formal invitation will follow in due course.
Should you be unable to attend, we kindly invite you to delegate your participation to your Deputy Secretary or another high-level representative from your ministry. Please inform us accordingly if the invitation is forwarded.
We are delighted to share that a number of distinguished speakers and guests have already confirmed their participation, and we sincerely hope to count you among them.
For more details, please visit the official conference website: http://www.copenhagenlifesciencesummit.dk/
Should you have any questions or require further information, please do not hesitate to contact us.
Kind regards,
Marie and Camilla
|
Antoinette Marie van de Vijver Jørgensen Senior Advisor
|
|
|
|
|
|
|
|
|
||
|
DK Odense M, 5230 | Forskerparken 10Y DK Copenhagen N, 2200 | BioInnovation Institute, Ole Maaløes Vej 3 |
|
|||
Camilla Simpson
International Affairs Advisor
M (+45) 2114 0731
Rigshospitalet – Denmark’s largest University Hospital
Section 11.41
Esther Møllers Vej 1, Entrance 11, 4. floor
2100 Copenhagen
1
Copenhagen Life Science Summit October 8-9
With a predominant focus on human health, the forthcoming European life science strategy will be an example of a forward-looking policy that intend to harness the poten<al of innova<on and new technologies while upholding the core principles of universal access to high-quality care – a hallmark of healthcare in Europe.
With the Compe<<veness Compass, the EU Commission has set a new poli<cal direc<on in which research and innova<on is at the heart of boos<ng European compe<<veness to ensure sustainable prosperity, aiming to develop and produce tomorrow's technologies – made in Europe innova<on. The Draghi Report highlights the life science industry, encompassing both pharmaceu<cals and medical devices, as an example of what the EU can achieve in technology and innova<ve product development.
On October 8-9, Rigshospitalet and Healthcare Denmark will host Copenhagen Life Science Summit as part of Denmark's EU Presidency (July 1 - December 31, 2025), which will be included in the official conference programme during the Presidency, focusing on the life science sector in a European context.
Copenhagen Life Science Summit will explore the state of the current EU health ecosystem in a global context highligh<ng the role for a strong ecosystem approach to European coopera<on between industry, academia, public health authori<es and pa<ents. The summit will contribute to the promo<on of Europe as a leading life science region, where new innova<ve health solu<ons are to the benefit of pa<ents and the European health systems.
The forthcoming EU Strategy for Life Sciences adopts an approach where “life sciences” as a term is broadly understood as the study of living systems, from microorganisms, plants, animals and human beings to ecosystems. It encompasses sectors from pharmaceu<cals to agriculture, energy, food and feed. The strategy will iden<fy key challenges and opportuni<es to speed up the safe development, deployment and uptake of life sciences-based innova<on, including to support the digital and green transi<ons of our society and economy. In this context Copenhagen Life Science Summit focuses specifically on life sciences in rela<on to human health. It includes research, innova<on, commercializa<on, scale up and implementa<on in pharmaceu<cals, biotechnology and medical technology as well as AI and other data driven and digitally enabled health care solu<on.
Copenhagen Life Science Summit aims to facilitate broad stakeholder discussions on a number of thema<c topics with the objec<ve to shape policy discussions and the EU Strategy for Life Sciences:
• On October 8, Rigshospitalet will host a high-level conference day: “Invest, Innovate, Collaborate, Elevate: Strategic Perspec<ves for an Innova<ve and Compe<<ve European Life Sciences Ecosystem" that will discuss and shape policy recommenda<ons in the context of the EU Strategy for Life Sciences. The conference will focus on transla<onal research and clinical trials, life science innova<on ecosystems, uptake of innova<ve health solu<ons and interdisciplinary infrastructures for transforma<ve life science R&I.
On October 8, Healthcare Denmark will host a standing dinner recep<on in Copenhagen City Hall.
• On October 9, Healthcare Denmark will host a high-level conference day: "Life Science: A Catalyst for European Compe<<veness" that will discuss how the European life science sector will be a catalyst for compe<<veness with a close link to the EU Compass. The conference will focus on how Europe, through public-private partnerships, can enhance compe<<veness and aaain strategic autonomy.
2
Preliminary Programme Wednesday October 8 Invest, Innovate, Collaborate, Elevate: Strategic Perspec7ves for an Innova7ve and Compe77ve European Life Sciences Ecosystem Venue: Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen
Time Content Speakers
8:30 Arrival, registra<on and networking
09:00 Welcome and fireside discussion
• Welcome by Rasmus Møgelvang, CEO, Rigshospitalet and Lars Gaardhøj, Chairman, Capital Region of Denmark.
• Fireside discussion by Margrethe Vestager and Enrico Le@a
(tbc) Moderator: Di@e Brasso Sørensen, Deputy Director, Think Tank EUROPA
09:30 Panel discussion
State of the current EU health ecosystem in a global context Moderated by: Di@e Brasso Sørensen, Deputy Director, Think Tank EUROPA • Elizabeth Macintyre, President, Biomedical Alliance in
Europe • Nathalie Moll, CEO, EFPIA (tbc) • Oliver Bisazza, CEO, MedTech Europe (tbc) • Ernst Kuipers, Vice President (Research), Nanyang
Technological University, Singapore; and Prev. Minister of Health, Welfare and Sport of the Netherlands
• Marco Greco, President of European Pa<ents Forum (tbc)
10:15 IntroducMon to break-out discussion by Di@e Brasso Sørensen, Deputy Director, Think Tank EUROPA
10:30 Coffee break
11:00 Walk to Roundtable discussions
3
11:15 Roundtable discussions
RTD 1: Strengthening applied transnaMonal and clinical research By Chair, CrisMna Messa, former Minister of University and Research, Italy; and Co-chair, Malene Fischer, Research Director, Rigshospitalet. RTD 2: BoosMng the innovaMon of the European life science industry By Chair, Prof. Chantal Mathieu, KU Leuven (tbc); and Co-chair, David Dreyer Lassen, Rector, University of Copenhagen. RTD3: SupporMng the uptake and implementaMon of medical technologies and health care soluMons By Chair, Heyo Kroemer, CEO, Charité (tbc); and Co-chair, Rasmus Møgelvang, CEO, Rigshospitalet. RTD 4: Securing EU as a world leader in personalised medicine and prevenMon By Chair, Jens Habermann, CEO, BBMRI-ERIC (tbc); and Co-chair: BeZna Lundgren, CEO, Danish Na<onal Genome Center (tbc). RTD 5: Addressing European regulatory challenges By Chair, Enrico Le@a, IE University’s School of Poli<cs, Economics and Global Affairs (tbc); and Co-chair Ida Sofie Jensen, CEO, Lif.
12:45 Walk to lunch area
13:00 Lunch & networking
14:00 Panel debate How to create a world class European Ecosystem in life sciences Moderator: Di@e Brasso Sørensen, Deputy Director, Think Tank EUROPA • David Dreyer Lassen, Rector, Copenhagen University • Thomas Hoffmann, Director, Technical University Munich,
Innova<on District Munich (tbc) • Rasmus Møgelvang, CEO, Rigshospitalet, Innova<on District
Copenhagen • TBA
14:30 Pre-
recommenda<ons from Roundtable discussions
• Applied translaMon and clinical research, by chair • Cross-sectoral partnerships and innovaMon districts, by chair • AdopMng efficient innovaMve soluMons while eliminaMng low
benefit health care, by chair
4
• A world leader in personalised medicine and prevenMon. How to make the most of data sharing, digitalisaMon, and the use of AI, by chair
• Addressing European regulatory challenges, by chair
15:20 Short break
15:40 Keynote • Mario Draghi, former President of European Central Bank & Author of the Future European Compe<<veness Report (tbc)
16:00 High level panel
debate Moderator: Di@e Brasso Sørensen, Deputy Director, Think Tank EUROPA • Ekatarina Zaharieva, Commissioner for Startups, Research,
and Innova<on, European Commission (tbc) • ChrisMna Egelund, Minister for Higher Educa<on & Science,
Denmark • European minister of health • Rasmus Møgelvang, CEO, Rigshospitalet
16:30 End of conference
5
Wednesday October 8 Life Science: A Catalyst for European Compe77veness Venue: Copenhagen City Hall, Raadhuspladsen 1, Copenhagen
Time Content Speakers
RecepMon at Copenhagen City Hall
17.30 Arrival, registra<on and networking
18.00 Welcome
Lars Weiss, Lord Mayor, Copenhagen
18.10 Opening remarks
Sophie Løhde, Minister for the Interior and Health, Denmark
18.30 Networking dinner
20.00 End of recep<on
Thursday October 9 Life Science: A Catalyst for European Compe77veness Venue: Mærsk Tower, Copenhagen University, Blegdamsvej 3B, Copenhagen N
Time Content Speakers
08.00 Arrival, registra<on and networking
09.00 Welcome and opening remarks
David Dreyer Lassen, Rector, University of Copenhagen & Lykke Friis, Director, Think Tank EUROPA
09.15 Opening Keynote Unlocking Europe’s PotenMal: A Life Sciences Strategy for Prosperity and Health • Stéphane Séjourné, Execu<ve Vice-President for Prosperity and
Industrial Strategy, European Commission (TBC) The opening keynote will present the Commission’s vision for strengthening Europe’s life sciences sector, detailing key policy
6
ini<a<ves under the Strategy for Life Sciences and the Compe<<veness Compass.
09.35 Keynote Losing Ground? Challenges for Europe’s Life Sciences Sector in the Global Race for InnovaMon • Elizabeth Kuiper, Associate Director and Head of the Social
Europe & Well-Being Programme, European Policy Centre The keynote will assess the core drivers of Europe’s compe<<veness in life sciences and iden<fy future policy challenges for the EU.
09.55 Panel Debate Back in the Lead: How to Design a European Industrial Policy for Public Health and InnovaMon Moderated by: Lykke Friis, Director, Think Tank EUROPA • Ekaterina Zaharieva, Commissioner for Startups, Research, and
Innova<on, European Commission (TBC) • Stefan Oelrich, President, European Federa<on of
Pharmaceu<cal Industries and Associa<on (TBC) • Mónica García Gómez, Minister of Health, Spain (TBC) • CEO, Novo Nordisk (TBC) • Dolors Montserrat, MEP; Member of Commiaee on the
Environment, Climate and Food Safety (ENVI), European Parliament (TBC)
The panel will debate the priori<es for EU industrial policy by exploring the risks and poten<al of tools such as public investment, policy reform, and joint procurement to drive innova<on in life sciences while advancing European public health objec<ves.
10.40 Coffee Break
11.10 Fireside chat Aligning Public Goals with Corporate Growth: Lessons from the Nordic Experience Moderated by: Lykke Friis, Director, Think Tank EUROPA • Lars Rasmussen, Chair of the Board for Coloplast and WS
Audiology; Chair of the Danish Life Science Council This session will present the lessons learned from the Nordic approach to public-private partnerships and explore how these strategies could be scaled at the European level.
7
11.25 Panel Debate Public-Private Partnerships: A Catalyst for European CompeMMveness and Health? Moderated by: Lykke Friis, Director, Think Tank EUROPA • Jennifer Carroll MacNeill, Minister for Health, Ireland (TBC) • KersMn Jorna, Director-General for DG Internal Market, Industry,
Entrepreneurship and SMEs (DG GROW), European Commission (TBC)
• Charl Van Zyl, CEO, H. Lundbeck • SMne Bosse, MEP, Vice-Chair on the Commiaee on Public Health
(SANT), European Parliament (TBC) The panel will examine the role of public-private partnerships in fostering life sciences innova<on and strengthening healthcare. Speakers will discuss how Europe can build more effec<ve na<onal and cross-border collabora<ons between the public and private sectors.
12.10 Networking Lunch
13.10 Keynote Why life science must be at the heart of Europe’s industrial strategy to drive innovaMon, economic resilience, and public health • Morten Bødskov, Minister for Industry, Business and Financial
Affairs, Denmark
13.30 Panel Debate Unlocking the Societal Value of InnovaMon: Shaping the Future of Resilient, Sustainable and InnovaMve Healthcare in Europe Moderated by: Di@e Brasso Sørensen, Deputy Director, ThinkTank EUROPA • Sandra Gallina, Director-General for DG for Health and Food
Safety (DG SANTE), European Commission • Søren Nedergaard, CPO - Porpolio, People & Partnerships, Novo
Nordisk Founda<on • Teresa Graham, CEO, Roche Pharmaceu<cal • Marco Greco, President, European Pa<ents Forum (TBC)
The conversa<on will assess how strategic investments in life sciences can strengthen healthcare systems across Europe through economic growth and improved pa<ent outcomes.
8
14.15 Keynote Aligning Public Goals with Corporate Growth: Lessons from Europe • Marc Ferracci, Minister for Industry and Energy, France (TBC)
14.30 Panel debate How to Boost Private Investment in Start-ups and Scale-ups: The
Role of RegulaMon and Capital Market Reform Moderated by: Di@e Brasso Sørensen, Deputy Director, ThinkTank EUROPA • Gelsomina VigloZ, Vice President, European Investment Bank
(TBC) • Jens Nielsen, CEO, BioInnova<on Ins<tute Founda<on,
Copenhagen • Kim Jørgensen (To be announced) • Rafaele Tordjman, Founder and CEO, Jeito Capital (TBC) • Pascal Canfin, MEP, Member of the Commiaee on the
Environment, Climate and Food (ENVI); and the Commiaee of Public Health (SANT), European Parliament (TBC)
This session will debate how the EU can bridge the private investment gap in life science research and innova<on – in par<cular what regulatory reforms are needed to unlock private funding and how the EU can steer capital markets towards socially beneficial investments.
15.15 Coffee Break
15.45 Panel Debate Spreading the Gains of CompeMMveness: Enhancing Access to InnovaMve Healthcare Across the EU Moderated by: Di@e Brasso Sørensen, Deputy Director, ThinkTank EUROPA • Anca Toma, Execu<ve Director, European Pa<ents Forum (TBC) • VlasMmil Válek, Deputy Prime Minister and Minister of Health,
Czech Republic (TBC) • Benjamin Roche@e, Vice President, Global Regulatory Affairs,
Coloplast • Audrey Duval, Execu<ve Vice President of Corporate Affairs,
Sanofi (TBC) • Radan Kanev, MEP, Member of the Commiaee on the
Environment, Climate and Food (ENVI), European Parliament (TBC)
9
The panel will discuss how the EU’s industrial strategy should be accompanied by measures to improve equitable access to innova<ve treatments and ensure that investments in new life sciences hubs deliver benefits across all member states, for example through regulatory reform, financing condi<onali<es, stronger coordina<on, or joint procurement.
16.30 Closing Remarks
Moving Forward: Next Steps for Europe • Lars Løkke Rasmussen, Minister for Foreign Affairs, Denmark
(TBC) The closing remarks will reflect on key takeaways from the conference and highlight ac<onable next steps for policymakers to reinforce Europe’s leadership in life sciences.
16.45 End of conference
16.45 Closing Recep<on
18.00 End of Closing Recep<on
SAVE THE DATE:
COPENHAGEN LIFE SCIENCE SUMMIT October 8-9 2025 | Copenhagen, Denmark
Join us for Copenhagen Life Science Summit, a two-day high-level conference - part of Denmark’s EU Presidency 2025 - hosted by Rigshospitalet and Healthcare Denmark, taking place in Copenhagen on October 8-9 2025.
The high-level conference will bring together academia, decision-makers, public health organisations, industry, and patient organisations from across EU27+, creating an international forum for the European life Science ecosystem to meet, exchange insights, and engage in discussions on the European Strategy for Life Sciences. The conference will explore the state of the current EU health and life science ecosystem, highlight the need for a strong, integrated European ecosystem, and create recommendations for the European Life Science Strategy and framework for research and innovation.
Together, we will explore how Europe can advance its position as a leading life science region – ensuring our competitiveness and contributing to more resilient, innovative health systems that benefit patients across Europe.
The two-day programme: • On October 8, Rigshospitalet will host the conference Invest, Innovate, Collaborate,
Elevate: Strategic Perspectives for an Innovative and Competitive European Life Sciences Ecosystem on-site at Rigshospitalet.
In the evening, Healthcare Denmark will host a standing dinner reception at Copenhagen City Hall.
• On October 9, Healthcare Denmark will host the conference Life Science: A Catalyst for European Competitiveness at Maersk Tower, Copenhagen University.
Please mark your calendars now! In July 2025, when Denmark will hold the Presidency of the Council of the European Union, official invitations and registration details will be shared.
For further information and to view the preliminary program, kindly visit the official webpage here: http://www.copenhagenlifesciencesummit.dk/
Copenhagen Life Science Summit is financially supported by the European Commission; the Danish Ministry for Industry, Business and Financial Affairs; the Danish Ministry for Higher Education and Science; and Novo Nordisk Foundation.
SAVE THE DATE:
COPENHAGEN LIFE SCIENCE SUMMIT October 8-9 2025 | Copenhagen, Denmark
Join us for Copenhagen Life Science Summit, a two-day high-level conference - part of Denmark’s EU Presidency 2025 - hosted by Rigshospitalet and Healthcare Denmark, taking place in Copenhagen on October 8-9 2025.
The high-level conference will bring together academia, decision-makers, public health organisations, industry, and patient organisations from across EU27+, creating an international forum for the European life Science ecosystem to meet, exchange insights, and engage in discussions on the European Strategy for Life Sciences. The conference will explore the state of the current EU health and life science ecosystem, highlight the need for a strong, integrated European ecosystem, and create recommendations for the European Life Science Strategy and framework for research and innovation.
Together, we will explore how Europe can advance its position as a leading life science region – ensuring our competitiveness and contributing to more resilient, innovative health systems that benefit patients across Europe.
The two-day programme: • On October 8, Rigshospitalet will host the conference Invest, Innovate, Collaborate,
Elevate: Strategic Perspectives for an Innovative and Competitive European Life Sciences Ecosystem on-site at Rigshospitalet.
In the evening, Healthcare Denmark will host a standing dinner reception at Copenhagen City Hall.
• On October 9, Healthcare Denmark will host the conference Life Science: A Catalyst for European Competitiveness at Maersk Tower, Copenhagen University.
Please mark your calendars now! In July 2025, when Denmark will hold the Presidency of the Council of the European Union, official invitations and registration details will be shared.
For further information and to view the preliminary program, kindly visit the official webpage here: http://www.copenhagenlifesciencesummit.dk/
Copenhagen Life Science Summit is financially supported by the European Commission; the Danish Ministry for Industry, Business and Financial Affairs; the Danish Ministry for Higher Education and Science; and Novo Nordisk Foundation.